HIGHLIGHTS
- who: Sam Hanash and Johannes F. Fahrmann from the Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Spain Department of Biostatistics, The University of Texas MD Anderson Center, Houston, TX, United States have published the research: Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer, in the Journal: (JOURNAL)
- how: To assess model reproducibility and stability the authors introduced perturbation into the dataset (e_g random selection with replacement) and re-evaluated model performance the results of which showed that the DLM was robust (Supplementary Table 4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.